44P Biomarker analysis from a phase Ib, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into metastatic and primary liver tumors

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; pp. S1390 - S1391
Main Authors Hecht, J.R., Peeters, M., Martin Jimenez, M., Pless, M., Cubillo, A., Garcia-Corbacho, J., Mach, N., Digklia, A., Park, H., Subbiah, V., Gorski, K., Anderson, A., Liu, C., Snyder, W., Chesney, J.
Format Journal Article
LanguageEnglish
Published 01.12.2021
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2021.10.060